Sensitive ASX Announcement

Noxopharm Secures Key European Patent Allowance for Veyonda

Published: 29/06/21, 12:42pm (AEST)2 pages
Noxopharm Limited
NOX:ASXHealthcare

Recent NOX Announcements

Price Sensitive only